Steven Lazarus - Net Worth and Insider Trading

Steven Lazarus Net Worth

The estimated net worth of Steven Lazarus is at least $110 Million dollars as of 2024-11-10. Steven Lazarus is the 10% Owner of Alnylam Pharmaceuticals Inc and owns about 222,500 shares of Alnylam Pharmaceuticals Inc (ALNY) stock worth over $62 Million. Steven Lazarus is also the Director of Amgen Inc and owns about 149,343 shares of Amgen Inc (AMGN) stock worth over $49 Million. Details can be seen in Steven Lazarus's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Steven Lazarus has not made any transactions after 2004-05-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Steven Lazarus

To

Steven Lazarus Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Steven Lazarus owns 7 companies in total, including Impinj Inc (PI) , Xtera Communications Inc (XCOMQ) , and NeurogesX Inc (NGSX) among others .

Click here to see the complete history of Steven Lazarus’s form 4 insider trades.

Insider Ownership Summary of Steven Lazarus

Ticker Comapny Transaction Date Type of Owner
PI Impinj Inc 2016-07-20 10 percent owner
XCOMQ Xtera Communications Inc 2015-11-17 10 percent owner
NGSX NeurogesX Inc 2011-07-21 10 percent owner
LIMIT LIMIT 2004-03-10 10 percent owner
LIMIT LIMIT 2004-05-27 10 percent owner
LIMIT LIMIT 2004-02-25 director
LIMIT LIMIT 2003-11-26 10 percent owner

Steven Lazarus Latest Holdings Summary

Steven Lazarus currently owns a total of 2 stocks. Among these stocks, Steven Lazarus owns 222,500 shares of Alnylam Pharmaceuticals Inc (ALNY) as of May 27, 2004, with a value of $62 Million and a weighting of 55.96%. Steven Lazarus also owns 149,343 shares of Amgen Inc (AMGN) as of February 25, 2004, with a value of $49 Million and a weighting of 44.04%.

Latest Holdings of Steven Lazarus

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALNY Alnylam Pharmaceuticals Inc 2004-05-27 222,500 277.43 61,728,175
AMGN Amgen Inc 2004-02-25 149,343 325.28 48,578,291

Holding Weightings of Steven Lazarus


Steven Lazarus Form 4 Trading Tracker

According to the SEC Form 4 filings, Steven Lazarus has made a total of 0 transactions in Alnylam Pharmaceuticals Inc (ALNY) over the past 5 years. The most-recent trade in Alnylam Pharmaceuticals Inc is the sale of 0 shares on May 27, 2004, which brought Steven Lazarus around $0.

According to the SEC Form 4 filings, Steven Lazarus has made a total of 0 transactions in Amgen Inc (AMGN) over the past 5 years. The most-recent trade in Amgen Inc is the sale of 10,000 shares on February 25, 2004, which brought Steven Lazarus around $642,200.

Insider Trading History of Steven Lazarus

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Steven Lazarus Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Steven Lazarus Ownership Network

Ownership Network List of Steven Lazarus

No Data

Ownership Network Relation of Steven Lazarus

Insider Network Chart

Steven Lazarus Owned Company Details

What does Impinj Inc do?

Who are the key executives at Impinj Inc?

Steven Lazarus is the 10 percent owner of Impinj Inc. Other key executives at Impinj Inc include director & Chief Executive Officer Diorio Chris Ph.d. , Chief Financial Officer Cary Baker , and Chief Operating Officer Hussein Mecklai .

Impinj Inc (PI) Insider Trades Summary

Over the past 18 months, Steven Lazarus made no insider transaction in Impinj Inc (PI). Other recent insider transactions involving Impinj Inc (PI) include a net sale of 203,464 shares made by Diorio Chris Ph.d. , a net sale of 77,435 shares made by Jeffrey Dossett , and a net sale of 64,309 shares made by Cary Baker .

In summary, during the past 3 months, insiders sold 832,037 shares of Impinj Inc (PI) in total and bought 4,264,393 shares, with a net purchase of 3,432,356 shares. During the past 18 months, 2,181,728 shares of Impinj Inc (PI) were sold and 5,740,087 shares were bought by its insiders, resulting in a net purchase of 3,558,359 shares.

Impinj Inc (PI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Impinj Inc Insider Transactions

No Available Data

Steven Lazarus Mailing Address

Above is the net worth, insider trading, and ownership report for Steven Lazarus. You might contact Steven Lazarus via mailing address: 8755 West Higgins Road, Suite 1025, Chicago Il 60631.